A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...
SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...
Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...
We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...
Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...
Antimicrobials, vaccines, and anti-inflammatories associated with reduced risk for Alzheimer disease and dementia.
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatmentAlzheimer's disease progression does ...
Alzheimer’s affects millions of Americans and can have a devastating impact on finances. Some of the worst damage is done before a diagnosis is even made.
The geroscience hypothesis focuses on extending the healthy lifespan by targeting aging mechanisms. Recent advances in ...
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
New research is drawing a connection between gut health and Alzheimer’s Disease. Scientists at ASU and Banner Alzheimer’s ...
The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...